<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.oncozine.com/wp-content/plugins/wpseo-news/assets/xml-news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url>
	<loc>https://www.oncozine.com/rebuilding-after-cancer-what-survivorship-surveillance-can-catch-sooner/</loc>
	<news:news>
		<news:publication>
			<news:name>Onco'Zine</news:name>
			<news:language>en</news:language>
		</news:publication>
		<news:publication_date>2026-09-15T18:20:14+00:00</news:publication_date>
		<news:title><![CDATA[Rebuilding After Cancer: What Survivorship Surveillance Can Catch Sooner]]></news:title>
	</news:news>
</url>
<url>
	<loc>https://www.oncozine.com/when-cancer-moves-to-the-liver-it-builds-an-entirely-different-support-structure/</loc>
	<news:news>
		<news:publication>
			<news:name>Onco'Zine</news:name>
			<news:language>en</news:language>
		</news:publication>
		<news:publication_date>2026-09-15T00:12:44+00:00</news:publication_date>
		<news:title><![CDATA[When Cancer Moves to the Liver, It Builds an Entirely Different Support Structure]]></news:title>
	</news:news>
</url>
<url>
	<loc>https://www.oncozine.com/destiny-lung04-shows-a-first-line-pfs-benefit-with-trastuzumab-deruxtecan-in-her2-mutant-nsclc-while-overall-survival-remains-uncertain/</loc>
	<news:news>
		<news:publication>
			<news:name>Onco'Zine</news:name>
			<news:language>en</news:language>
		</news:publication>
		<news:publication_date>2026-09-14T21:03:32+00:00</news:publication_date>
		<news:title><![CDATA[DESTINY-Lung04 Shows a First-Line PFS Benefit With Trastuzumab Deruxtecan in HER2-Mutant NSCLC, While Overall Survival Remains Uncertain]]></news:title>
	</news:news>
</url>
<url>
	<loc>https://www.oncozine.com/zidesamtinib-moves-toward-the-front-line-new-arros-1-data-in-treatment-naive-ros1-positive-ln-nsclc/</loc>
	<news:news>
		<news:publication>
			<news:name>Onco'Zine</news:name>
			<news:language>en</news:language>
		</news:publication>
		<news:publication_date>2026-09-14T16:03:44+00:00</news:publication_date>
		<news:title><![CDATA[Zidesamtinib Moves Toward the Front Line &#8211; New ARROS-1 Data in Treatment-Naive ROS1-Positive Lung Cancer]]></news:title>
	</news:news>
</url>
<url>
	<loc>https://www.oncozine.com/the-hidden-oncology-gatekeepers-shaping-access-to-life-saving-cancer-therapies/</loc>
	<news:news>
		<news:publication>
			<news:name>Onco'Zine</news:name>
			<news:language>en</news:language>
		</news:publication>
		<news:publication_date>2026-09-14T10:46:56+00:00</news:publication_date>
		<news:title><![CDATA[The Hidden Oncology Gatekeepers Shaping Access to Life-Saving Cancer Therapies]]></news:title>
	</news:news>
</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->